The data are based on a survey conducted during the 2nd quarter of 2015. It describes major drivers for personalized medicine according to pharmaceutical companies in Asia, Europe, and in the U.S. Some 73% of respondents stated that a greater use of data analytics in trials will be a top driver for personalized medicine.
Greater use of data analytics in trials | 73 |
New delivery systems (i.e. 3D printing, online pharmacy) | 69 |
New research in pharmacogenomics | 57 |
Regulatory incentives/guidance | 54 |
Wearable technology as companion diagnostics | 52 |